E. Benson

发表

Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients.

D. Cooper, D. Moss, T. Sculley, 1992, AIDS research and human retroviruses.

Phenotypic variability: clinical presentation between the 6th year and the 60th year in a family with X-linked agammaglobulinemia.

D. Gillis, E. Benson, M. Gold, 2004, The Journal of allergy and clinical immunology.

Imiquimod: Potential risk of an immunostimulant

E. Benson, 2004, The Australasian journal of dermatology.

STANDARDISATION OF ANCA TESTING ACROSS AUSTRALASIAN LABORATORIES: IMPACT OF THE INTERNATIONAL CONSENSUS STATEMENT

E. Benson, 2002, Pathology.

Identification of WASP mutations in 10 Australian families with Wiskott–Aldrich syndrome and X‐linked thrombocytopenia

S. Weston, E. Edkins, E. Benson, 2004, Pathology.

A Novel Autocrine Pathway of Tumor Escape from Immune Recognition: Melanoma Cell Lines Produce a Soluble Protein That Diminishes Expression of the Gene Encoding the Melanocyte Lineage Melan-A/MART-1 Antigen Through Down-Modulation of Its Promoter

I. S. Dunn, P. J. van den Elsen, E. Benson, 2001, The Journal of Immunology.

Promoter Antigen Through Down-Modulation of Its the Melanocyte Lineage Melan-A/MART-1 Diminishes Expression of the Gene Encoding Lines Produce a Soluble Protein That from Immune Recognition: Melanoma Cell A Novel Autocrine Pathway of Tumor Escape

Boyle, I. S. Dunn, E. Benson, 2001 .

Promoter Antigen Through Down-Modulation of Its the Melanocyte Lineage MelanA / MART-1 Diminishes Expression of the Gene Encoding Lines Produce a Soluble Protein That from Immune Recognition : Melanoma Cell

Boyle, I. S. Dunn, E. Benson, 2001 .

Induction of "antigen silencing" in melanomas by oncostatin M: down-modulation of melanocyte antigen expression.

I. S. Dunn, E. Benson, J. Kurnick, 2003, Molecular cancer research : MCR.

Enhancement of Human Melanoma Antigen Expression by IFN-β1

I. S. Dunn, E. Benson, J. Kurnick, 2007, The Journal of Immunology.

Immunologic manipulation for the threatened fetus.

E. Benson, 2004, Thrombosis research.

Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus

S. L. Silins, J. Burrows, D. Moss, 1996, Journal of virology.

The Usefulness Of A Rapid Pcr Methodology To Detect Rearranged Ig Heavy Chain Genes In Lymphoproliferative Disease In A Diagnostic Setting

B. Bennetts, E. Benson, M. Tschuchnigg, 1995, Pathology.

A syndromic rash in patients attending methadone clinics in New South Wales

E. Benson, L. Snell, J. Currie, 2005 .

Zidovudine therapy in HIV-related thrombocytopenia.

E. Benson, R. Kwiatek, P. Elliott, 1989, Australian and New Zealand journal of medicine.

Whither smooth muscle antibodies in the third millennium?

R. Silvestrini, E. Benson, 2001, Journal of clinical pathology.

Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed?

C. Mullighan, S. Weston, S. Weston, 2001, Clinical and experimental immunology.

Translocations into human chromosome 14 JH region: factors influencing downstream abortive immunoglobulin class switching.

I. S. Dunn, E. Benson, J. A. Hughes, 2003, Molecular immunology.

Necrotizing vasculitis secondary to propylthiouracil presenting as purpura fulminans.

E. Benson, D. Chipps, K. E. Park, 1999, Rheumatology.

Role of the Mitogen-Activated Protein Kinase Signaling Pathway in the Regulation of Human Melanocytic Antigen Expression

I. S. Dunn, E. Benson, J. Kurnick, 2006, Molecular Cancer Research.

Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives

S. Weston, E. Benson, M. Velickovic, 2004, Journal of Clinical Pathology.

The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting.

V. Gebski, J. Boyages, E. Benson, 1999, Pathology.

Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individuals.

G. Stewart, D. Cooper, A. Kelleher, 1999, AIDS research and human retroviruses.

Optic neuropathy in chronic lymphocytic leukemia.

D. Albert, S. Lessell, E. Benson, 1988, Archives of ophthalmology.

Human interleukin‐5 induces staphylococcal A Cowan 1 strain‐activated human B cells to secrete IgM

E. Benson, C. Sanderson, J. Bertolini, 1993, European journal of immunology.

THE APPLICATION OF A PCR TECHNIQUE FOR THE DETECTION OF IMMUNOGLOBULIN HEAVY CHAIN GENE REARRANGEMENTS IN FRESH OR PARAFFIN‐EMBEDDED SKIN TISSUE

S. Weston, B. Bennetts, S. Jolles, 2001, Pathology.

Quantifiable analysis of human immunoglobulin heavy chain class-switch recombination to all isotypes.

I. S. Dunn, E. Benson, J. A. Hughes, 2000, Journal of immunological methods.

Procalcitonin: A Marker of Bacteraemia in SIRS

K. Byth, R. Silvestrini, E. Benson, 2003, Anaesthesia and intensive care.

International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

R J Falk, J C Jennette, A. Wiik, 1999, American journal of clinical pathology.

Increased frequency of CCR‐5 Δ32 heterozygotes among long‐term non‐progressors with HIV‐1 infection

J. Kaldor, G. Stewart, D. Cooper, 1997 .

Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.

J. Savige, R. Silvestrini, D. Fulcher, 1999, Journal of clinical pathology.

Interleukin 12-augmented T cell proliferation of peripheral blood mononuclear cells from HIV-seropositive individuals is associated with interleukin 12 receptor beta 2 upregulation.

Matthew Jones, R. Puls, E. Benson, 2003, AIDS research and human retroviruses.

SERUM INTERLEUKIN ‐ 2 RECEPTOR LEVELS AND CUTANEOUS T‐CELL LYMPHOMA

J. Kelly, E. Benson, Stephen J. Gilmore, 1991, The Australasian journal of dermatology.

In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by interleukin-12 (IL-12).

G. Stewart, D. Fulcher, E. Benson, 2001, AIDS research and human retroviruses.

Tracking membrane and secretory immunoglobulin α heavy chain mRNA variation during B‐cell differentiation by real‐time quantitative polymerase chain reaction

I. S. Dunn, E. Benson, S. Xiang, 2001, Immunology and cell biology.

Identification of the bruton tyrosine kinase (BTK) gene mutations in 20 Australian families with X‐linked agammaglobulinemia (XLA)

S. Weston, E. Benson, M. Velickovic, 2004, Human mutation.

Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group.

J. Kaldor, G. Stewart, D. Cooper, 1997, AIDS.

A syndromic rash in patients attending methadone clinics in New South Wales

K. Scrivener, E. Benson, Jimmy Chien, 2005, The Medical journal of Australia.

Intravenously administered IgG for the treatment of thyroid eye disease

J. Dwyer, E. Benson, J. O'day, 1991 .

Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group.

J. Matthews, J. Matthews, E. Benson, 1994, Blood.

Eye movement abnormalities as a predictor of the acquired immunodeficiency syndrome dementia complex.

David A. Cooper, B. Ramsden, J. Currie, 1988, Archives of neurology.

Immune modulation in HIV infection: fact or fantasy?

E. Benson, 1993, Journal of acquired immune deficiency syndromes.